CXCL12 and Miyoshi myopathy: Fifty MM patients were enrolled in the study; however, 4 patients did not completethe four chemotherapy cycles and, therefore, 46 patients were available for theanalysis of changes in cEPCs and SDF-1α after chemotherapy.